LAURA OVERTON: Open Payments
NPI 1891339958 · HUMBLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,232 in 57 payments from 18 companies in 2025. Trend: 2023 $109 · 2024 $637 · 2025 $1,232
Food & beverage: $1,147Education: $85
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $221 |
| Astellas Pharma US Inc | 3 | $134 |
| Neurocrine BioSciences, Inc. | 4 | $119 |
| SANOFI-AVENTIS U.S. LLC | 6 | $116 |
| Madrigal Pharmaceuticals | 3 | $94 |
| ABBVIE INC. | 4 | $76 |
| Corcept Therapeutics | 4 | $66 |
| Exact Sciences Corporation | 3 | $61 |
| Lilly USA, LLC | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
Products named: Ozempic, CRENESSITY, TZIELD, REZDIFFRA, Wegovy, Korlym, Cologuard Collection Kit, MOUNJARO.
Industry payments across TX — which companies pay providers there.
